353.2 🩺 國考版

353.2.1 高頻考點

353.2.1.1 Acute Pancreatitis Etiology

  • Gallstones (50%, women)
  • Alcohol (25-30%, men)
  • Hypertriglyceridemia (TG > 1000)
  • Drugs
  • ERCP
  • Trauma
  • Hypercalcemia
  • Genetic

353.2.1.2 Diagnosis (2 of 3)

  • Abdominal pain
  • Lipase > 3x ULN
  • Imaging

353.2.1.3 Severity (Atlanta 2012)

  • Mild: no OF
  • Moderate: transient OF or local complications
  • Severe: persistent OF > 48 h

353.2.1.4 Severity Markers

  • BISAP score
  • CRP > 150 at 48 h
  • Hemoconcentration
  • Persistent SIRS

353.2.1.5 Treatment AP

  • Aggressive IV LR (PAMPHLET trial)
  • Analgesia
  • Early oral feeding > NJ > TPN
  • ERCP within 24-72 h for gallstone with cholangitis
  • Antibiotics ONLY if infected necrosis
  • Cholecystectomy before discharge (mild gallstone AP)

353.2.1.6 Local Complications

  • Acute fluid collection
  • Pseudocyst (4+ weeks, non-epithelial)
  • Acute necrotic collection
  • Walled-off necrosis (WON)
  • Step-up approach (PANTER trial)
  • Endoscopic transmural drainage preferred

353.2.1.7 Chronic Pancreatitis

  • Alcohol most common
  • Smoking independent risk
  • Pain + exocrine + endocrine insufficiency
  • Diagnosis: CT, MRCP, EUS, fecal elastase
  • Treatment: alcohol cessation + PERT + insulin + analgesia

353.2.1.8 PERT (Pancreatic Enzyme Replacement)

  • For exocrine insufficiency
  • 25,000-75,000 units lipase per meal
  • ADEK vitamins

353.2.1.9 Type 3c Diabetes

  • Pancreatic diabetes
  • Brittle
  • Often requires insulin

353.2.1.10 Autoimmune Pancreatitis

  • Type 1: IgG4-related; elderly males; sausage-shaped pancreas
  • Type 2: Idiopathic duct-centric; younger; IBD association
  • Steroid-responsive

353.2.1.11 Pancreatic Pseudocyst

  • ≥ 4 weeks
  • Asymptomatic + < 6 cm: observe
  • Symptomatic: endoscopic transmural drainage preferred

353.2.1.12 Key Trials

  • PAMPHLET: LR > NS for AP
  • WATERFALL: moderate fluid resuscitation
  • PANTER: step-up approach for necrotizing pancreatitis

353.2.2 易混淆比范

Type Cause Treatment
AP gallstone Stone obstruction ERCP + cholecystectomy
AP alcohol Toxic + secretagogue Cessation + supportive
AP HTG TG > 1000 Insulin + heparin + apheresis
AIP Type 1 IgG4-related Steroids
AIP Type 2 Idiopathic duct-centric Steroids
CP Alcohol, smoking PERT + alcohol cessation
Pseudocyst Post-AP Observation or endoscopic

353.2.3 Special Topics

353.2.3.1 Pancreas Divisum

  • Failure of dorsal-ventral fusion
  • Drainage via accessory papilla
  • Some develop pancreatitis
  • ERCP with minor papilla sphincterotomy

353.2.3.2 Hereditary Pancreatitis

  • PRSS1 (cationic trypsinogen) — autosomal dominant
  • SPINK1 (trypsin inhibitor) — modifier
  • CFTR (cystic fibrosis)
  • CASR (calcium-sensing receptor)
  • ↑ Risk pancreatic cancer

353.2.3.4 Pancreatic Cancer Risk in CP

  • Particularly hereditary
  • Long-standing
  • Imaging surveillance